>
Switch to:

Allergy Therapeutics ROCE %

: -31.31% (As of Jun. 2021)
View and export this data going back to 2004. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Allergy Therapeutics's annualized ROCE % for the quarter that ended in Jun. 2021 was -31.31%.


Allergy Therapeutics ROCE % Historical Data

The historical data trend for Allergy Therapeutics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
ROCE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.79 -16.87 10.01 14.26 6.36

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
ROCE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.30 52.58 -20.98 43.34 -31.31

Allergy Therapeutics ROCE % Calculation

Allergy Therapeutics's annualized ROCE % for the fiscal year that ended in Jun. 2021 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2021 )  (A: Jun. 2020 )(A: Jun. 2021 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2021 )  (A: Jun. 2020 )(A: Jun. 2021 )
=5.8176718092567/( ( (107.91614518148 - 22.812265331665) + (123.54698457223 - 25.568022440393) )/ 2 )
=5.8176718092567/( (85.103879849812+97.978962131837)/ 2 )
=5.8176718092567/91.541420990825
=6.36 %

Allergy Therapeutics's ROCE % of for the quarter that ended in Jun. 2021 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2021 )  (Q: Dec. 2020 )(Q: Jun. 2021 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2021 )  (Q: Dec. 2020 )(Q: Jun. 2021 )
=-32.726507713885/( ( (133.0685483871 - 21.978494623656) + (123.54698457223 - 25.568022440393) )/ 2 )
=-32.726507713885/( ( 111.09005376344 + 97.978962131837 )/ 2 )
=-32.726507713885/104.53450794764
=-31.31 %

Note: The EBIT data used here is two times the semi-annual (Jun. 2021) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics  (OTCPK:AGYTF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Allergy Therapeutics ROCE % Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)